Hubei University of Chinese Medicine/The Co-innovation Center for Preventive Treatment of Disease of Acupuncture-moxibustion in Hubei Province.
Department of Acupuncture, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.
Medicine (Baltimore). 2020 Dec 18;99(51):e23728. doi: 10.1097/MD.0000000000023728.
Obesity is a chronic metabolic disease in which patients are overweight due to the excessive accumulation of fat in the body. As a subtype of acupuncture, catgut embedding at acupoints has increased in clinical application for obesity. The aim of this study is to evaluate the effectiveness and safety of acupoint catgut embedding therapy for simple obesity.
Electronic searches of the Cochrane Library, PubMed, Springer Medline, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI), Wan-Fang Data (WANFANG), Chinese Biomedical Literature Database (CBM), and Chinese Scientific Journal Database (VIP databases) will be performed. The Chinese Clinical Trial Registry Center and the ClinicalTrials.gov registry will also be searched for ongoing trials. Databases will be searched from inception to August 2020.Randomized controlled clinical trials (RCTs) will be included if acupoint catgut embedding was evaluated as the sole treatment (diet or exercise therapy as the control group will be allowed) for simple obesity. The primary outcomes will consist of the improvement rate and reduction in body weight (BW). The secondary outcomes will include body mass index (BMI), waist circumference (WC), fat percentage (F %) and adverse effects. Two reviewers will undertake the study selection, data extraction and assessments of study quality. After screening the studies, the quality of the included studies will be assessed according to the quality criteria specified by the Cochrane Handbook for Systematic Reviews of Interventions (version 5.1.0). Meta-analysis will be performed by RevMan 5.3 software.
According to the data of improvement rate and reduction in BW, BMI, WC, and F %, this study will provide an evidence-based review of acupoint catgut embedding therapy for simply.
This systematic review will present the current evidence for acupoint catgut embedding therapy for obesity.
Ethical approval is not necessary since this protocol is only for systematic review and does not involve privacy data. The findings of this study will be disseminated electronically through a peer-review publication or presented at a relevant conference.
INPLASY2020110045.
肥胖是一种慢性代谢性疾病，由于体内脂肪过度积累，患者超重。穴位埋线作为针灸的一种亚类，在肥胖症的临床应用中逐渐增多。本研究旨在评估穴位埋线疗法治疗单纯性肥胖的有效性和安全性。
我们将对 Cochrane 图书馆、PubMed、Springer Medline、EMBASE、Web of Science、中国国家知识基础设施（CNKI）、万方数据（WANFANG）、中国生物医学文献数据库（CBM）和中国科技期刊数据库（VIP 数据库）进行电子检索。还将检索中国临床试验注册中心和 ClinicalTrials.gov 注册中心正在进行的试验。检索数据库的时间从建库至 2020 年 8 月。如果穴位埋线作为单纯性肥胖的单一治疗方法（允许饮食或运动疗法作为对照组）进行评估，我们将纳入随机对照临床试验（RCT）。主要结局将包括改善率和体重减轻（BW）。次要结局将包括体重指数（BMI）、腰围（WC）、脂肪百分比（F%）和不良反应。两名评审员将进行研究选择、数据提取和研究质量评估。筛选研究后，将根据 Cochrane 干预系统评价手册（版本 5.1.0）规定的质量标准评估纳入研究的质量。Meta 分析将使用 RevMan 5.3 软件进行。
根据改善率和 BW、BMI、WC 和 F%的降低数据，本研究将为穴位埋线治疗单纯性肥胖提供循证评价。
本系统评价将提供穴位埋线治疗肥胖症的最新证据。
由于本方案仅为系统评价，不涉及隐私数据，因此不需要伦理批准。本研究的结果将通过同行评议发表或在相关会议上展示。
INPLASY2020110045。
